Cargando…

Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer

Detalles Bibliográficos
Autores principales: Ahn, Soomin, Lee, Jong- chan, Shin, Dong Woo, Kim, Jaihwan, Hwang, Jin‑ Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713644/
https://www.ncbi.nlm.nih.gov/pubmed/33273671
http://dx.doi.org/10.1038/s41598-020-78512-x
_version_ 1783618597706268672
author Ahn, Soomin
Lee, Jong- chan
Shin, Dong Woo
Kim, Jaihwan
Hwang, Jin‑ Hyeok
author_facet Ahn, Soomin
Lee, Jong- chan
Shin, Dong Woo
Kim, Jaihwan
Hwang, Jin‑ Hyeok
author_sort Ahn, Soomin
collection PubMed
description
format Online
Article
Text
id pubmed-7713644
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77136442020-12-08 Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer Ahn, Soomin Lee, Jong- chan Shin, Dong Woo Kim, Jaihwan Hwang, Jin‑ Hyeok Sci Rep Author Correction Nature Publishing Group UK 2020-12-03 /pmc/articles/PMC7713644/ /pubmed/33273671 http://dx.doi.org/10.1038/s41598-020-78512-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Ahn, Soomin
Lee, Jong- chan
Shin, Dong Woo
Kim, Jaihwan
Hwang, Jin‑ Hyeok
Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title_full Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title_fullStr Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title_full_unstemmed Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title_short Author Correction: High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
title_sort author correction: high pd-l1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713644/
https://www.ncbi.nlm.nih.gov/pubmed/33273671
http://dx.doi.org/10.1038/s41598-020-78512-x
work_keys_str_mv AT ahnsoomin authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer
AT leejongchan authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer
AT shindongwoo authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer
AT kimjaihwan authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer
AT hwangjinhyeok authorcorrectionhighpdl1expressionisassociatedwiththerapeuticresponsetopembrolizumabinpatientswithadvancedbiliarytractcancer